Results 301 to 310 of about 184,386 (363)

Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology

open access: yesEuropean Journal of Heart Failure, EarlyView.
For most patients with chronic, progressive illnesses, maintaining good quality of life (QoL), with preserved functional capacity, is just as crucial as prolonging survival. Patients with heart failure (HF) experience much worse QoL and effort intolerance than both the general population and people with other chronic conditions, since they present a ...
Maurizio Volterrani   +21 more
wiley   +1 more source

Anticoagulation during Use of a Left Ventricular Assist Device

open access: bronze, 2000
Tatsuhiko Takahama   +2 more
openalex   +1 more source

Preventive catheter ablation for ventricular arrhythmias in patients with end‐stage heart failure referred for heart transplantation evaluation: Rationale for and design of the CASTLE‐VT trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
Aims Timely referrals for transplantation and left ventricular assist device (LVAD) play a key role in favourable outcomes in patients with advanced heart failure (HF). Cardiovascular mortality, driven by sudden cardiac death, is the main reason for dying while waiting for heart transplantation (HTx). The purpose of the Preventive Catheter Ablation for
Christian Sohns   +17 more
wiley   +1 more source

Anesthetic Approach for Non-Cardiac Procedures in Patients with a Left Ventricular Assist Device. [PDF]

open access: yesJ Clin Med
Comino-Trinidad O   +4 more
europepmc   +1 more source

Knowledge and application of ESC/HFA guidelines in the management of advanced heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
Knowledge and application of European Society of Cardiology/Heart Failure Association (ESC/HFA) guidelines in the management of advanced heart failure (HF). MCS, mechanical circulatory support. Aims Management of advanced heart failure (HF) remains challenging despite specific sections in the 2021 European Society of Cardiology/Heart Failure ...
Guillaume Baudry   +11 more
wiley   +1 more source

Current and novel biomarkers in cardiogenic shock

open access: yesEuropean Journal of Heart Failure, EarlyView.
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy